Bothell, Washington
United States
41
2021-10-28
The entities that hold a legal rights for patent applications filed by inventor KESICKI Edward A.:
Edward A. KESICKI from Bothell, US has applied for patents for these inventions. The list has both pending applications and granted patents:
QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
#2 | 2020-02-27Inhibitors of human phosphatidylinositol 3-kinase delta
#3 | 2020-01-16Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
#4 | 2018-12-20Inhibitors of human phosphatidylinositol 3-kinase delta
#5 | 2018-07-12SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
#6 | 2018-03-15SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
#7 | 2017-11-30Inhibitors of human phosphatidylinositol 3-kinase delta
#8 | 2017-05-25Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#9 | 2017-02-23INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
#10 | 2017-01-05TRPA1 modulators
#11 | 2016-08-18SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
#12 | 2016-03-17(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
#13 | 2016-01-14Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#14 | 2014-12-255-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
#15 | 2014-08-21NOVEL QUINOXALINE INHIBITORS OF PI3K
#16 | 2014-06-05Inhibitors of human phosphatidylinositol 3-kinase delta
#17 | 2014-05-015-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
#18 | 2014-05-015-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
#19 | 2013-05-096-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
#20 | 2012-07-05Inhibitors of human phosphatidylinositol 3-kinase delta
#21 | 2012-05-31Inhibitors of human phosphatidylinositol 3-kinase delta
#22 | 2012-01-19QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
#23 | 2011-01-27INHIBITORS OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE DELTA
#24 | 2010-10-07Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
#25 | 2010-10-07QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA
#26 | 2010-08-26THIENOPYRIMIDIONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS
#27 | 2010-07-01Inhibitors of human phosphatidylinositol 3-kinase delta
#28 | 2010-06-17Inhibitors of human phosphatidylinositol 3-kinase delta
#29 | 2010-04-29COMPOUNDS USEFUL FOR INHIBITING CHK1
#30 | 2010-01-14Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#31 | 2009-06-04Heteroaryl urea derivatives useful for inhibiting CHK1
#32 | 2008-11-06Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
#33 | 2008-04-17Materials and methods to potentiate cancer treatment
#34 | 2007-07-19Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
#35 | 2007-02-20Materials and methods to potentiate cancer treatment
#36 | 2006-06-27Compounds useful for inhibiting Chk1
#37 | 2006-04-06Cyclic AMP-specific phosphodiesterase inhibitors
#38 | 2006-02-14Cyclic AMP-specific phosphodiesterase inhibitors
#39 | 2005-11-24Inhibitors of human phosphatidylinositol 3-kinase delta
#40 | 2005-11-03Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
#41 | 2005-09-27Inhibitors of human phosphatidyl-inositol 3-kinase delta
236331 ⎘